Prognostic value of a novel circulating serum 90K antigen in breast cancer.
about
Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin.Influences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinoma90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cellsExpression of the 90K immunostimulator gene is controlled by a promoter with unique featuresQuantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model.Cyclophilin C-associated protein (CyCAP) knock-out mice spontaneously develop colonic mucosal hyperplasia and exaggerated tumorigenesis after treatment with carcinogen azoxymethane.Identification of Mac-2-binding protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomes.An Impermeant Ganetespib Analog Inhibits Extracellular Hsp90-Mediated Cancer Cell Migration that Involves Lysyl Oxidase 2-like ProteinCandidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas.Functional screen for secreted proteins by monoclonal antibody library and identification of Mac-2 Binding protein (Mac-2BP) as a potential therapeutic target and biomarker for lung cancerExpression and significance of 90K/Mac-2BP in prostate cancer.Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs.Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus.Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma.Prognostic relevance of LGALS3BP in human colorectal carcinoma.Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.Quantitative Proteomics Reveals the Roles of Peroxisome-associated Proteins in Antiviral Innate Immune Responses.Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer.Shoc2-tranduced ERK1/2 motility signals--Novel insights from functional genomics.Expression of tumor-associated 90K-antigen in human breast cancer: no correlation with prognosis and response to first-line therapy with tamoxifen.A list of candidate cancer biomarkers for targeted proteomics.90K Glycoprotein Promotes Degradation of Mutant β-Catenin Lacking the ISGylation or Phosphorylation Sites in the N-terminus.Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer.A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus.Human urine proteomics: building a list of human urine cancer biomarkers.Monoclonal antibodies specific for human tumor-associated antigen 90K/Mac-2 binding protein: tools to examine protein conformation and function.Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer.Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP).Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: identification of new signaling elements.LGALS3BP, lectin galactoside-binding soluble 3 binding protein, promotes oncogenic cellular events impeded by antibody intervention.LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis.SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.Secretome-based proteomics reveals sulindac-modulated proteins released from colon cancer cells.Overexpression and elevated plasma level of tumor-associated antigen 90K/Mac-2 binding protein in colorectal carcinoma.90K/Mac-2 binding protein is expressed in prostate cancer and induces promatrilysin expression.Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancer.Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection.Serum WFA+ -M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection.A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis.
P2860
Q24533183-F7880208-B51B-4CC8-A353-1B816E14CE93Q28216866-36624CCB-9F68-4074-8D5C-99BC76532CBAQ28264174-85851F27-B5C7-4EC2-A032-593E6C3AF09AQ28302428-CEA635EA-03A4-4CAD-97E0-129C9491A91FQ30576595-8196D0FE-2F5F-4270-92D1-01110F094EF2Q33220040-E2DC8B93-2A59-4E8F-B9B0-15A8C4F8EECAQ33486171-33D0124C-5D0F-46F7-9F79-95CDCCE01A0AQ33812900-9D49FBF5-74B1-4DAE-A586-0FC45CCD6ADCQ33820289-77FE9F8E-B093-429D-8258-6D16674E817AQ33883005-EA4A75CC-4FAB-4184-95C6-0EF5D84CC28FQ34489456-6051C8F8-6476-45B2-A4BD-7FCD0B5BD65BQ34515531-863C5DE4-1DFB-475D-BBAE-9CCD69F25863Q34580364-742B98E4-D73A-40D5-B1BC-5E5D27269017Q34583337-6D0B9AAF-9C03-4639-A929-3C73D4CEE411Q35098547-2842F4B0-0754-4C37-A3F7-74D2277B10A2Q35899039-50B10AA3-5044-43CB-8116-90753CD20150Q35931701-A040B581-0F9B-4A40-9D21-CCFB310193B3Q36040422-87C3BD29-B7DD-4B23-81A2-D95476BDAAA5Q36408948-056461B1-A252-49F2-B2D2-43C57DBCF930Q36677993-D9E9729D-839B-4D23-9A97-EC81BC9B4C05Q36687802-0188EDB9-8C62-4D9C-A0AD-AFE9D96E05E1Q37277962-7D789566-7BC9-4A8E-9227-2853680452E7Q37284950-0C19C6E6-A184-47A7-BA8E-C997292B5D39Q37363290-971B95D9-1897-43EB-B15D-BB618DA66950Q37742466-84796266-1382-4679-8602-9BD631CB3D9BQ37890422-6B1A6335-7436-4112-81D9-E30A7F2ED254Q38313181-C4626442-D0D3-46A8-B87A-80E102DC43BEQ38315227-7364BEE9-2B27-4797-AA04-7ABD2A5536FCQ38352962-CFAF62FA-3E3E-41AD-8BA8-79AAA41E5310Q38425184-30FAABAD-9CE4-45BB-9FB8-5F3259291561Q39041034-5926DC3F-F8E5-407B-B6C4-C8A0488A1F6FQ39302172-A10DC135-3D45-4091-8CD6-1FDE509A1E1DQ39671092-1A84F084-03A9-459E-9CD1-B86C054437C5Q39866787-2B75D026-D733-4233-8ADE-B076FA17BC04Q39911230-FD26CC4D-9FFC-4AA9-9C29-8577119BEEA6Q40358677-DA55AB5D-836B-4F35-ACA6-10D86C43E7D7Q40571479-41B5F68C-56F3-4662-93FE-10A7C9E111D7Q40735572-4CA501CA-3D14-4697-880E-7788FC338F6BQ40776645-42D7816E-D017-4F66-B916-353F34BAC45BQ42233241-28358670-D43B-43CE-BA5E-A62CDE6858A2
P2860
Prognostic value of a novel circulating serum 90K antigen in breast cancer.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Prognostic value of a novel circulating serum 90K antigen in breast cancer.
@ast
Prognostic value of a novel circulating serum 90K antigen in breast cancer.
@en
type
label
Prognostic value of a novel circulating serum 90K antigen in breast cancer.
@ast
Prognostic value of a novel circulating serum 90K antigen in breast cancer.
@en
prefLabel
Prognostic value of a novel circulating serum 90K antigen in breast cancer.
@ast
Prognostic value of a novel circulating serum 90K antigen in breast cancer.
@en
P2093
P2860
P356
P1476
Prognostic value of a novel circulating serum 90K antigen in breast cancer
@en
P2093
C Amatetti
M D'Egidio
P Di Stefano
P Sismondi
S Iacobelli
P2860
P2888
P304
P356
10.1038/BJC.1994.29
P407
P577
1994-01-01T00:00:00Z